Display options
Cite
Meysamie A, Salarvand F, Khorasanizadeh M, et al. Cardiovascular risk assessment by FRS and SCORE in Iranian adult population. J Diabetes Metab Disord. 2017;16:35doi: 10.1186/s40200-017-0316-4.
Meysamie, A., Salarvand, F., Khorasanizadeh, M., Ghalehtaki, R., Eskian, M., Ghodsi, S., Ghalehtaki, S., Abbasi, M., Etemad, K., Asgari, F., & Esteghamati, A. (2017). Cardiovascular risk assessment by FRS and SCORE in Iranian adult population. Journal of diabetes and metabolic disorders, 1635. https://doi.org/10.1186/s40200-017-0316-4
Meysamie, Alipasha, et al. "Cardiovascular risk assessment by FRS and SCORE in Iranian adult population." Journal of diabetes and metabolic disorders vol. 16 (2017): 35. doi: https://doi.org/10.1186/s40200-017-0316-4
Meysamie A, Salarvand F, Khorasanizadeh M, Ghalehtaki R, Eskian M, Ghodsi S, Ghalehtaki S, Abbasi M, Etemad K, Asgari F, Esteghamati A. Cardiovascular risk assessment by FRS and SCORE in Iranian adult population. J Diabetes Metab Disord. 2017 Aug 23;16:35. doi: 10.1186/s40200-017-0316-4. eCollection 2017. PMID: 28852642; PMCID: PMC5568064.
Copy Download .nbib Format: NLM
Share it on

J Diabetes Metab Disord. 2017 Aug 23;16:35. doi: 10.1186/s40200-017-0316-4. eCollection 2017.

Cardiovascular risk assessment by FRS and SCORE in Iranian adult population.

Journal of diabetes and metabolic disorders

Alipasha Meysamie, Fereshteh Salarvand, MirHojjat Khorasanizadeh, Reza Ghalehtaki, Mahsa Eskian, Saeed Ghodsi, Shirin Ghalehtaki, Mehrshad Abbasi, Koroush Etemad, Fereshteh Asgari, Alireza Esteghamati

Affiliations

  1. Department of Community and Preventive Medicine, Faculty of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  2. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  4. Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  5. School of Medicine, Ahvaz Jondishapour University of Medical Sciences, Ahvaz, Iran.
  6. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  7. Center for Disease Control, Ministry of Health, Tehran, Iran.

PMID: 28852642 PMCID: PMC5568064 DOI: 10.1186/s40200-017-0316-4

Abstract

BACKGROUND: Handling the growing epidemic of coronary heart disease in developing nations hinges on primary prevention, which logistically requires directing preventive interventions to those at the highest risk. Therefore, implementing cardiovascular risk assessment profiles is crucial to distinguish high risk groups who truly need extensive preventive measures. We aimed to draw a picture of the cardiovascular risk profiles in the Iranian adult population for the first time.

METHODS: Demographic, anthropometric, and laboratory data as well as blood pressure and smoking status of 3944 subjects participating in the 2011 national surveillance of risk factors for non-communicable diseases were used to calculate the mean estimated risk of coronary artery disease and the relative frequency of low-, medium- and high-risk subjects based on FRS and SCORE indices in general population as well as different age, sex, and residence subgroups.

RESULTS: The average 10-year risk of coronary artery disease (FRS) and 10-year risk of fatal coronary and cerebrovascular accidents (SCORE) in the 25 to 64 year-old population was 13.82 and 0.72 respectively. The relative frequency of the intermediate- and high- risk subjects was 25.8 and 22.6% based on FRS and 9.2 and 1.8% based on SCORE respectively. Average FRS and SCORE were significantly higher among men than women, but were not significantly different among urban and rural residents.

CONCLUSIONS: A significant proportion of the Iranian population, based on FRS model, will be at moderate to high risk of coronary events in the next 10 years. Urgent preventive plans are needed at the national level.

Keywords: Cardiovascular disease; Coronary heart disease; FRS; Iran; Risk assessment; Risk factors; SCORE

References

  1. Nutr J. 2012 Sep 10;11:69 - PubMed
  2. Int J Cardiol. 2016 Jan 15;203:893-9 - PubMed
  3. Arch Intern Med. 2005 Dec 12-26;165(22):2644-50 - PubMed
  4. J Am Coll Cardiol. 2004 May 19;43(10):1791-6 - PubMed
  5. Heart. 2006 Dec;92(12):1752-9 - PubMed
  6. Maturitas. 2010 Mar;65(3):262-6 - PubMed
  7. Circulation. 2008 Feb 12;117(6):743-53 - PubMed
  8. BMC Cardiovasc Disord. 2007 Oct 30;7:32 - PubMed
  9. Am J Epidemiol. 2012 Aug 1;176(3):177-86 - PubMed
  10. Atherosclerosis. 2010 Dec;213(2):345-51 - PubMed
  11. Diabetes Care. 2009 Nov;32(11):2094-8 - PubMed
  12. Eur Heart J. 2003 Jun;24(11):987-1003 - PubMed
  13. Bull World Health Organ. 2010 Feb;88(2):120-30 - PubMed
  14. BMJ Open. 2015 May 19;5(5):e007324 - PubMed
  15. Int J Clin Pract. 2011 Mar;65(3):264-73 - PubMed
  16. Eur J Cardiovasc Prev Rehabil. 2010 Apr;17 (2):223-9 - PubMed
  17. Lancet. 2010 May 1;375(9725):1536-44 - PubMed
  18. Arch Iran Med. 2013 Mar;16(3):138-44 - PubMed
  19. JAMA. 1990 Dec 19;264(23):3018-24 - PubMed
  20. BMC Public Health. 2009 May 29;9:167 - PubMed
  21. J Diabetes. 2017 May;9(5):518-525 - PubMed
  22. Scand J Prim Health Care. 2010 Dec;28(4):242-8 - PubMed
  23. East Mediterr Health J. 2009 Jan-Feb;15(1):157-66 - PubMed
  24. Arch Iran Med. 2010 Jul;13(4):340-50 - PubMed

Publication Types